Alternatives to Atomic-AI

AI-powered drug discovery and development platform for biologics.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Develops AI-powered tools for scientific research and discovery, focusing on drug discovery and materials science.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Leveraging the adaptive immune system to diagnose and treat disease.

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Mapping cell-cell communication at scale in human tissue.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

AI-powered platform for personalized cell therapy development and manufacturing.

Advance every cancer decision.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.